$PDSB IMO, the company needs to do a better job of showing what all they are doing - regardless of how early on their pipeline is. I understand PDS0101 is furthest along and is their baby at this point but their investor deck certainly does a poor job outlining timelines. This slide is great! But they should have one that shows ALL possible milestones with EVERYTHING in their pipeline. This goes all the way out to the end of Q4 2022....Seems to me there will be also be several other catalysts within that time frame yet you would never know by looking at their presentation. There's nothing wrong with bringing more attention to other aspects of their pipeline in addition to PDS0101, regardless of whether or not things are in preclinical stage.
  • 1
1 Like